Esmolol for better oxygen in ARDS patients
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests if esmolol, a heart-slowing drug, can improve oxygen levels in patients with acute respiratory distress syndrome (ARDS) who are on a breathing machine. It may help by adjusting heart rate to a specific range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute respiratory distress syndrome (ARDS) as defined by standard criteria.
- You are between 18 and 65 years old.
- Your resting heart rate is between 95 and 120 beats per minute.
- You need a breathing tube and a mechanical ventilator.
- You (or your legal representative) can sign a consent form.
- You do not have certain heart conditions, like a slow heart rate or advanced heart block, and are not already taking beta-blockers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether erythropoietin (EPO), a medicine that affects red blood cell production, can help clear extra fluid from the lungs in people with acute respiratory distress syndrome (ARDS). If it works, it could improve breathing and reduce lung fluid buildup during critical illness.
This trial tests a full-course strategy using a heart-lung bypass machine (ECMO) for people with moderate-to-severe acute respiratory distress syndrome (ARDS), a serious lung condition. The goal is to see if starting and continuing ECMO throughout treatment improves recovery.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
This study tests whether a medicine called esmolol (a beta-blocker) can help your heart recover while you are on a heart-lung machine (V-A ECMO). It is for adults with severe heart failure who are already on certain heart medicines.
This study tests a medication called esmolol to see if it helps blood flow in tiny blood vessels under the tongue for people with septic shock. If you have a fast heart rate despite treatment, this trial may help your doctors better manage your condition.
This study tests a heart-slowing medicine called esmolol (a beta-blocker) in people with septic shock and a fast heart rate. It uses ultrasound to see if the medicine is safe and helpful.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.